SK372003A3 - Cyclic substituted aminomethyl compounds and medicaments containing said compounds - Google Patents

Cyclic substituted aminomethyl compounds and medicaments containing said compounds Download PDF

Info

Publication number
SK372003A3
SK372003A3 SK37-2003A SK372003A SK372003A3 SK 372003 A3 SK372003 A3 SK 372003A3 SK 372003 A SK372003 A SK 372003A SK 372003 A3 SK372003 A3 SK 372003A3
Authority
SK
Slovakia
Prior art keywords
formula
compounds
alkyl
pharmaceutically acceptable
cycloalkyl
Prior art date
Application number
SK37-2003A
Other languages
English (en)
Slovak (sk)
Inventor
Oswald Karl Zimmer
Babette-Yvonne Kogel
Wolfgang Werner A Strassburger
Original Assignee
Gruenenthal Chemie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gruenenthal Chemie filed Critical Gruenenthal Chemie
Publication of SK372003A3 publication Critical patent/SK372003A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D335/06—Benzothiopyrans; Hydrogenated benzothiopyrans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/06—Anti-spasmodics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
    • C07C211/29—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by halogen atoms or by nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/46—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C215/64—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/74—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
    • C07D313/02—Seven-membered rings
    • C07D313/06—Seven-membered rings condensed with carbocyclic rings or ring systems
    • C07D313/08—Seven-membered rings condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D337/00—Heterocyclic compounds containing rings of more than six members having one sulfur atom as the only ring hetero atom
    • C07D337/02—Seven-membered rings
    • C07D337/06—Seven-membered rings condensed with carbocyclic rings or ring systems
    • C07D337/08—Seven-membered rings condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/12—One of the condensed rings being a six-membered aromatic ring the other ring being at least seven-membered

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
SK37-2003A 2000-07-10 2001-07-06 Cyclic substituted aminomethyl compounds and medicaments containing said compounds SK372003A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10033459A DE10033459A1 (de) 2000-07-10 2000-07-10 Cyclische substituierte Aminomethylverbindungen und diese Verbindungen enthaltende Arzeimittel
PCT/EP2001/007750 WO2002008218A1 (de) 2000-07-10 2001-07-06 Cyclische substituierte aminomethylverbindungen und diese verbindungen enthaltende arzneimittel

Publications (1)

Publication Number Publication Date
SK372003A3 true SK372003A3 (en) 2003-06-03

Family

ID=7648406

Family Applications (1)

Application Number Title Priority Date Filing Date
SK37-2003A SK372003A3 (en) 2000-07-10 2001-07-06 Cyclic substituted aminomethyl compounds and medicaments containing said compounds

Country Status (27)

Country Link
US (1) US6890952B2 (pl)
EP (1) EP1299373B1 (pl)
JP (1) JP2004504394A (pl)
KR (1) KR100821113B1 (pl)
CN (1) CN1179958C (pl)
AR (1) AR032464A1 (pl)
AT (1) ATE286891T1 (pl)
AU (2) AU6912401A (pl)
BR (1) BR0112447A (pl)
CA (1) CA2415196A1 (pl)
CZ (1) CZ301135B6 (pl)
DE (2) DE10033459A1 (pl)
EC (1) ECSP034416A (pl)
ES (1) ES2234851T3 (pl)
HU (1) HUP0302817A3 (pl)
IL (2) IL153825A0 (pl)
MX (1) MXPA02012925A (pl)
MY (1) MY134060A (pl)
NO (1) NO20030105L (pl)
NZ (1) NZ523089A (pl)
PE (1) PE20020255A1 (pl)
PL (1) PL204123B1 (pl)
PT (1) PT1299373E (pl)
RU (1) RU2003102610A (pl)
SK (1) SK372003A3 (pl)
WO (1) WO2002008218A1 (pl)
ZA (1) ZA200301048B (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004034619A1 (de) 2004-07-16 2006-02-23 Grünenthal GmbH Substituierte Aminoverbindungen als 5-HT/NA Uptakehemmer
US7378552B2 (en) * 2005-06-07 2008-05-27 Neurocrine Biosciences, Inc. Monoamine re-uptake inhibitors and methods relating thereto

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE922703C (de) 1951-02-03 1955-01-24 Hans Kenner Stanzvorlage zum Ausstanzen von Reissverschlusskrampen und Verfahren sowie Vorrichtung zum Herstellen derselben
CH391722A (de) * 1958-03-20 1965-05-15 Ciba Geigy Verfahren zur Herstellung von 3-Aralkyl-2-tert.-amino-alkyl-indenen
US3072716A (en) * 1959-03-18 1963-01-08 Ciba Geigy Corp Substituted indenes
US3142682A (en) * 1961-11-21 1964-07-28 Ciba Geigy Corp Tertiary amino derivatives of chromans and homo-chromans
US3956391A (en) 1973-06-04 1976-05-11 Sandoz, Inc. Amino substituted tetrahydropleiadenes
JPS61130287A (ja) * 1984-11-30 1986-06-18 Suntory Ltd 1−ベンズオキセピン誘導体
DE19805370A1 (de) * 1997-03-14 1998-09-17 Gruenenthal Gmbh Substituierte Aminoverbindungen und ihre Verwendung als analgetisch wirksame Substanzen
DE19755480A1 (de) * 1997-12-13 1999-06-24 Gruenenthal Gmbh Substituierte heterocyclische Benzocycloalkene und ihre Verwendung als analgetisch wirksame Substanzen

Also Published As

Publication number Publication date
AU6912401A (en) 2002-02-05
HUP0302817A3 (en) 2005-02-28
MY134060A (en) 2007-11-30
EP1299373A1 (de) 2003-04-09
CZ200388A3 (cs) 2003-04-16
KR100821113B1 (ko) 2008-04-11
PT1299373E (pt) 2005-05-31
KR20030040351A (ko) 2003-05-22
US6890952B2 (en) 2005-05-10
EP1299373B1 (de) 2005-01-12
DE10033459A1 (de) 2002-01-24
CN1441796A (zh) 2003-09-10
ECSP034416A (es) 2003-04-25
MXPA02012925A (es) 2003-05-15
PL204123B1 (pl) 2009-12-31
NO20030105D0 (no) 2003-01-09
NZ523089A (en) 2005-07-29
HK1054932A1 (en) 2003-12-19
ZA200301048B (en) 2004-05-06
RU2003102610A (ru) 2004-07-10
US20030166708A1 (en) 2003-09-04
HUP0302817A1 (hu) 2003-12-29
AR032464A1 (es) 2003-11-12
CN1179958C (zh) 2004-12-15
NO20030105L (no) 2003-02-05
CZ301135B6 (cs) 2009-11-18
CA2415196A1 (en) 2003-01-08
DE50105073D1 (de) 2005-02-17
PE20020255A1 (es) 2002-05-18
IL153825A (en) 2008-04-13
AU2001269124B2 (en) 2006-03-30
PL360389A1 (pl) 2004-09-06
ATE286891T1 (de) 2005-01-15
IL153825A0 (en) 2003-07-31
ES2234851T3 (es) 2005-07-01
JP2004504394A (ja) 2004-02-12
BR0112447A (pt) 2003-07-08
WO2002008218A1 (de) 2002-01-31

Similar Documents

Publication Publication Date Title
US8278338B2 (en) Saturated and unsaturated 3-pyridyl-benzocycloalkylmethyl-amines for use in treating pain, depression and/or anxiety
AU771252B2 (en) Methods and compounds for treating depression and other disorders
JP2665422B2 (ja) 置換された1,2,3,4−テトラヒドロシクロペント〔b〕インドール、1,2,3,3a,4,8a−ヘキサヒドロシクロペント〔b〕インドールおよび関連化合物
KR100213531B1 (ko) 헥사히드로아제핀 유도체, 그것들의 제법과 그것들을 함유하는 약학 조성물
US5942529A (en) Benzisothiazolyl-substituted aminomethylchromans
KR100748378B1 (ko) 아미노메틸-페닐-사이클로헥사논 유도체
AU2001269124B2 (en) Cyclic substituted aminomethyl compounds and medicaments containing said compounds
US5158948A (en) Tetracyclic spirobenzazepine dopamine antagonists
KR100456795B1 (ko) 헤테로시클로알킬벤조시클로부탄 및 헤테로아릴벤조시클로부탄 화합물, 이들의 제조방법 및 이들을 포함하는 약제 조성물
US7041697B2 (en) Antidepressant cycloalkylamine derivatives of 2,3-dihydro-1,4-benzodioxan
US7064236B2 (en) Substituted 1-aryl-but-3-enylamine and 1-aryl-but-2-enylamine compounds
IE902313A1 (en) 2-amino-1,2,3,4-tetrahydronaphthalene derivatives with¹cardiovascular activity, process for their preparation and¹pharmaceutical compositions containing them
CA2573754C (en) Substituted amino compounds as 5-ht/na uptake inhibitors
HK1054932B (en) Cyclic substituted aminomethyl compounds and medicaments containing said compounds
US20040162432A1 (en) Substituted octahydrophenanthrene compounds and use thereof as NMDA antagonists
JPWO1996022276A1 (ja) エチルアミン誘導体及び医薬
EP1790337A2 (en) Methods and compounds for treating depression and other disorders

Legal Events

Date Code Title Description
FB9A Suspension of patent application procedure